Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Minority Interest: 2020-2022

Historic Minority Interest for Cullinan Therapeutics (CGEM) over the last 1 years, with Jun 2022 value amounting to $80,000.

  • Cullinan Therapeutics' Minority Interest fell 97.33% to $80,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $80,000, marking a year-over-year decrease of 97.33%. This contributed to the annual value of $403,000 for FY2021, which is 69.10% down from last year.
  • According to the latest figures from Q2 2022, Cullinan Therapeutics' Minority Interest is $80,000, which was down 89.58% from $768,000 recorded in Q1 2022.
  • Cullinan Therapeutics' Minority Interest's 5-year high stood at $3.0 million during Q2 2021, with a 5-year trough of $80,000 in Q2 2022.
  • In the last 3 years, Cullinan Therapeutics' Minority Interest had a median value of $1.3 million in 2020 and averaged $1.5 million.
  • Data for Cullinan Therapeutics' Minority Interest shows a maximum YoY tumbled of 97.33% (in 2022) over the last 5 years.
  • Over the past 3 years, Cullinan Therapeutics' Minority Interest (Quarterly) stood at $1.3 million in 2020, then slumped by 69.10% to $403,000 in 2021, then slumped by 97.33% to $80,000 in 2022.
  • Its Minority Interest stands at $80,000 for Q2 2022, versus $768,000 for Q1 2022 and $403,000 for Q4 2021.